Apatinib Combined With S-1 for the Treatment of Recurrent/Metastatic Head and Neck Malignancies
Condition: Head and Neck Cancer Intervention: Drug: Apatinib Sponsors: China International Medical Foundation; Chinese Society of Clinical Oncology Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials